Job Specifications
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
Join argenx
At argenx, we build our culture from the collective power of the team and the knowledge that together, we are better. If you are entrepreneurial, curious and committed to make a difference for patients and thrive on creating solutions for rare autoimmune diseases, then argenx is for you.
Next to a competitive salary with extensive benefits, we offer you the chance to grow and be a part of a team driven by purpose, creativity, innovation and science.
argenx
argenx is a fast-growing global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Thanks to colleagues based in Europe, the United States and Japan, we translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
For the expansion of our INTERNATIONAL Medical Affairs and Evidence Generation team, argenx is looking for a Medical Science Liaison Emerging Therapies, located in Belgium.
PURPOSE OF THE FUNCTION
The Medical Science Liaison Emerging Therapies, INTERNATIONAL Medical Affairs and Evidence Generation team will focus on communicating clinical data and providing scientific expertise, about argenx investigational products, and compounds in development, in a strictly scientific, non-promotional manner, and in full compliance with argenx policies and procedures. MSL Emerging Therapies serves to enhance the scientific credibility of the Company with key scientific institutions by supporting scientific dialogue and collaborations in the areas of research, medical and scientific exchange, including facilitation of requests for scientific and medical information.
Roles And Responsibilities
This MSL role will cover the Netherlands and Belgium, with regular face-to-face meetings with KOLs in these countries. It will also include mainly virtual engagements with stakeholders in Canada, Australia, and the Middle East - primarily in the UAE and Saudi Arabia.
Act as a subject matter expert for pipeline products in preclinical and early-phase clinical stages and be acknowledged internally and externally as an expert. Be an expert presenter, facilitator at advisory boards, expert meetings etc;
Identify potential high-impact medical research projects and publication opportunities (e.g., white papers to inform treatment guidelines), in line with argenx identified areas of interest to support enterprise objectives;
Identification of disease specific KOLs/HCPs to build a cross specialty KOL map for future indications to lay a foundation for successful launches;
Develop and maintain relationships with KOLs to collaborate on research projects, advisory boards and peer-to-peer educational initiatives ;
Responsible for the supervision of experts and centres in a number of European countries to be defined;
Ensure timely and informative scientific/medical exchange and education for HCPs on topics like disease awareness, diagnostics, treatment and adherence that accurately reflects scientific data and research objectives, compliantly and in line with the medical strategy;
Act as a key resource for scientific and clinical questions related to pipeline development and product lifecycle. Respond to questions from the healthcare community with integrity, compliance, and adherence to all legal, regulatory, and argenx guidelines, policies & procedure ;
Provide KOLs with the latest clinical data and emerging scientific trends relevant to the pipeline, facilitating meaningful scientific discussions;
Initiate and support high impact medical activities, such as advisory boards, congress symposia, hospital meetings, speaker development programs and reimbursement agency education;
Lead or participate in the training and education of internal teams on therapeutic areas, pipeline assets, and scientific advancements;
Communicate key clinical and scientific findings from ongoing trials to relevant stakeholders, ensuring that the information is understood and accurately represented;
Collaborate and provide input in the creation of medical strategies for pre-launch and early-stage pipeline products by staying informed about industry trends, competitive landscapes, and scientific developments in relevant therapeutic areas;
Attend appropriate international cong